Rankings
▼
Calendar
LUNG Q4 2019 Earnings — Pulmonx Corporation Revenue & Financial Results | Market Cap Arena
LUNG
Pulmonx Corporation
$72M
Q4 2019 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$10M
Gross Profit
$7M
70.9% margin
Operating Income
-$4M
-41.5% margin
Net Income
-$5M
-45.1% margin
EPS (Diluted)
$-0.23
QoQ Revenue Growth
+13.7%
Cash Flow
Operating Cash Flow
-$3M
Free Cash Flow
-$4M
Stock-Based Comp.
$167,000
Balance Sheet
Total Assets
$54M
Total Liabilities
$241M
Stockholders' Equity
-$187M
Cash & Equivalents
$15M
← FY 2019
All Quarters
Q1 2020 →